ResearchForecast

  Global demand for Hospital Supplies is expected to rise at a 3.7% CAGR from 2022 to 2032. The Hospital Supplies Market is expected to be worth US$ 29.5 billion in 2022. According to the study, hospitals will hold a significant 47.2% share of the global hospital supplies market in 2021. For more information: https://www.futuremarketinsights.com/reports/hospital-supplies-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Hospital Supplies market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Hospital Supplies market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, ...

  Global demand for Electrophoresis is expected to grow at a 4.7% CAGR from 2022 to 2032, with a market value of around US$ 2.2 billion in 2022. According to Future Market Insights, reagents and consumables will account for approximately 48.7% of the global market share in 2021. Get Full Access: https://www.futuremarketinsights.com/reports/electrophoresis-market Ongoing technological advancements in the medical and healthcare sector and rising demand for novel therapies and drugs, together with rising research projects allied with certain biomolecules are the key driving factors for the electrophoresis market. Developing markets with improving healthcare infrastructure and high disposable income are expected to fuel the electrophoresis market’s expansion throughout the forecast period. In contrast, because electrophoresis takes a long time to complete, it may act as a key restraint on the market because it only allows for restricted sample analysis. Electrophoresis market...

  In fiscal year 2023, the global Parkinson's Disease Market is expected to be worth US$ 5.41 billion, up from US$ 4.82 billion in fiscal year 2022. The global market is expected to grow at a 12.2% CAGR between 2023 and 2033, reaching a value of US$ 17.12 billion by the end of 2033. For more information: https://www.futuremarketinsights.com/reports/parkinsons-disease-market According to the Parkinson's Foundation, males are more likely than women to have Parkinson's disease. Men were discovered to have a higher occurrence, and their risk was shown to be around 1.5 times higher than that of women. Most often, those over 60 are affected by it. A number of the symptoms of Parkinson's disease can be alleviated with medication and other therapy methods including exercise. Drugs including safinamide, levodopa, benztropine, pramipexole, and selegiline are important therapy options for Parkinson's disease patients. Increasing pharmacological approvals for Parkinson...

  The Medical Home Services Market is expected to reach US$ 251.3 billion by 2022. Furthermore, the medical home services market is expected to grow at an 8.4% CAGR through 2032, reaching US$ 611.7 Billion. Get Full Access: https://www.futuremarketinsights.com/reports/patient-centered-medical-home-services-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Medical Home Services market.  FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Medical Home Services market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcare sector has been expanding remarkably...

  The Global Digital Health Market is expected to reach a valuation of US$ 2585.98 Bn by 2032, with sales growing at an astounding CAGR of 27.7% from 2022 to 2032. Owing to the rising awareness of digital health benefits, the market for the same is likely to expand at a rapid rate and reach an estimated US$ 224.24 Bn by the end of 2022. Get Complete Access: https://www.futuremarketinsights.com/reports/global-digital-health-market The deep penetration of electronic gadgets and devices and advancing technology coupled with the rising acceptance of telemedicine and telehealth services will fuel the growth of the digital health market during the forecast period. With the rapid digitalization of the healthcare sector, the prospects for the digital health market are also set to rise. Increasing usage of advanced technological tools like Big Data and others bodes well for the target market. Telemedicine and telehealth services are also on the rise and are increasingly adopted by b...

  The global Disposable Insulin-Delivery Device Market is worth US$ 14.59 Billion as of now and is expected to reach US$ 32.89 Billion by the year 2032 at a CAGR of 7.7% between 2022 and 2032. As per the International Diabetes Federation (IDF), one-tenth of the total population affected by diabetes has Type 1. Moreover, out of these, 10% do not use insulin delivery devices. This factor is bound to offer lucrative opportunities for the growth of disposable insulin-delivery device market in the forecast period. Get Full Access: https://www.futuremarketinsights.com/reports/disposable-insulin-delivery-device-market Out of syringes, pumps, pens, and jet injectors, pens hold the largest market share. They, in fact, account for more than 36% of the overall revenue. This could be reasoned with factors like higher rate of adoption and comprehendible design. On these grounds, NovoPen has been dominating the market. It has memory function as well. With disposable insulin-deliver...